GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins

Journal of Lipid Research

Volumn 50, Issue SUPPL., 2009, Pages

  Beigneux, Anne P ^a   Davies, Brandon S J ^a   Bensadoun, André ^b   Fong, Loren G ^a   Young, Stephen G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Chylomicrons; Endothelial; Glycosylphosphatidylinositol; Lipoprotein lipase; PPAR

Indexed keywords

CARRIER PROTEIN; LIPOPROTEIN; LIPOPROTEIN TRIGLYCERIDE; MEMBRANE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ANIMAL; CHEMISTRY; CLASSIFICATION; GENETICS; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; METABOLISM; REVIEW;

ANIMALS; CARRIER PROTEINS; HUMANS; HYPERLIPIDEMIAS; LIPID METABOLISM; LIPOPROTEINS; MEMBRANE GLYCOPROTEINS; PPAR GAMMA; TRIGLYCERIDES;

EID: 66349124432     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800030-JLR200     Document Type: Review

References (29)

1. Korn, E. D. 1955. Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil. J. Biol. Chem. 215: 15-26.
2. Brunzell, J. D., and S. S. Deeb. 2001. Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency. In The Metabolic and Molecular Bases of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle, B. Childs, K. W. Kinzler, and B. Vogelstein, editors. McGraw-Hill, New York. 2789-2816.
3. Havel, R. J., and J. P. Kane. 2001. Introduction: Structure and metabolism of plasma lipoproteins. In The Metabolic and Molecular Bases of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle, B. Childs, K. W. Kinzler, and B. Vogelstein, editors. McGraw-Hill, New York. 2705-2716.
4. Tan, M. H., T. Sata, and R. J. Havel. 1977. The significance of lipoprotein lipase in rat skeletal muscles. J. Lipid Res. 18: 363-370. (Pubitemid 8114143)
5. Inaba, T., M. Matsuda, M. Shimamura, N. Takei, N. Terasaka, Y. Ando, H. Yasumo, R. Koishi, M. Makishima, and I. Shimomura. 2003. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J. Biol. Chem. 278: 21344-21351. (Pubitemid 36792529)
6. Ito, Y., N. Azrolan, A. O'Connell, A. Walsh, and J. L. Breslow. 1990. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science. 249: 790-793.
7. Pennacchio, L. A., M. Olivier, J. A. Hubacek, J. C. Cohen, D. R. Cox, J-C. Fruchart, R. M. Krauss, and E. M. Rubin. 2001. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294: 169-173. (Pubitemid 32952971)
8. Yoshida, K., T. Shimizugawa, M. Ono, and H. Furukawa. 2002. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 43: 1770-1772. (Pubitemid 35315796)
9. Beigneux, A. P., B. Davies, P. Gin, M. M. Weinstein, E. Farber, X. Qiao, P. Peale, S. Bunting, R. L. Walzem, J. S. Wong, et al. 2007. Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 5: 279-291. (Pubitemid 46477852)
10. Véniant, M. M., A. P. Beigneux, A. Bensadoun, L. G. Fong, and S. G. Young. 2008. Lipoprotein size and susceptibility to atherosclerosis - insights from genetically modified mouse models. Curr. Drug Targets. 9: 174-189. (Pubitemid 351843598)
11. Young, S., B. S. J. Davies, L. G. Fong, P. Gin, M. M. Weinstein, A. Bensadoun, and A. P. Beigneux. 2007. GPIHBP1 - an endothelial cell molecule required for the lipolytic processing of chylomicrons. Curr. Opin. Lipidol. 18: 389-396. (Pubitemid 47051916)
12. Ioka, R. X., M-J. Kang, S. Kamiyama, D-H. Kim, K. Magoori, A. Kamataki, Y. Ito, Y. A. Takei, M. Sasaki, T. Suzuki, et al. 2003. Expression cloning and characterization of a novel glycosylphosphatidylinositol- anchored high density lipoprotein-binding protein, GPI-HBP1. J. Biol. Chem. 278: 7344-7349. (Pubitemid 36800737)
13. Weinstock, P. H., C. L. Bisgaier, K. Aalto-Setälä, H. Radner, R. Ramakrishnan, S. Levak-Frank, A. D. Essenburg, R. Zechner, and J. L. Breslow. 1995. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired low density lipoprotein clearance in heterozygotes. J. Clin. Invest. 96: 2555-2568.
14. Fry, B. G., W.Wuster, R. M. Kini, V. Brusic, A. Khan, D. Venkataraman, and A. P. Rooney. 2003. Molecular evolution and phylogeny of elapid snake venom three-finger toxins. J. Mol. Evol. 57: 110-129. (Pubitemid 36920455)
15. Mallya, M., R. D. Campbell, and B. Aguado. 2006. Characterization of the five novel Ly-6 superfamily members encoded in the MHC, and detection of cells expressing their potential ligands. Protein Sci. 15: 2244-2256. (Pubitemid 44496379)
16. Kieffer, B., P. C. Driscoll, I. D. Campbell, A. C. Willis, P. A. van der Merwe, and S. J. Davis. 1994. Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins. Biochemistry. 33: 4471-4482. (Pubitemid 24145093)
17. Stroncek, D. F., L. Caruccio, and M. Bettinotti. 2004. CD177: A member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera. J. Transl. Med. 2: 8.
18. Noel, L. S., B. R. Champion, C. L. Holley, C. J. Simmons, D. C. Morris, J. A. Payne, J. M. Lean, T. J. Chambers, G. Zaman, L. E. Lanyon, et al. 1998. RoBo-1, a novel member of the urokinase plasminogen activator receptor/CD59/Ly-6/snake toxin family selectively expressed in rat bone and growth plate cartilage. J. Biol. Chem. 273: 3878-3883. (Pubitemid 28103244)
19. Llinas, P., M. H. Le Du, H. Gardsvoll, K. Dano, M. Ploug, B. Gilquin, E. A. Stura, and A. Menez. 2005. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J. 24: 1655-1663. (Pubitemid 40704976)
20. Andermann, K., F. Wattler, S. Wattler, G. Heine, M. Meyer, W. G. Forssmann, and M. Nehls. 1999. Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily. Protein Sci. 8: 810-819. (Pubitemid 29165411)
21. Levitin, F., M. Weiss, Y. Hahn, O. Stern, R. L. Papke, R. Matusik, S. R. Nandana, R. Ziv, E. Pichinuk, S. Salame, et al. 2008. PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity. J. Biol. Chem. 283: 16928-16939.
22. Beigneux, A. P., P. Gin, B. S. Davies, M. M. Weinstein, A. Bensadoun, R. O. Ryan, L. G. Fong, and S. G. Young. 2008. Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipase. J. Lipid Res. 49: 1312-1321.
23. Gin, P., L. Yin, B. S. Davies, M. M. Weinstein,R. O. Ryan, A. Bensadoun, L. G. Fong, S. G. Young, and A. P. Beigneux. 2008. The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons. J. Biol. Chem. In press.
24. Bodian, D. L., S. J. Davis, B. P. Morgan, and N. K. Rushmere. 1997. Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59. J. Exp. Med. 185: 507-516. (Pubitemid 27078369)
25. Davies, B. S., H. Waki, A. P. Beigneux, E. Farber, M. M. Weinstein, D. C. Wilpitz, L. J. Tai, R. M. Evans, L. G. Fong, P. Tontonoz, et al. 2008. The expression of GPIHBP1, an Endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by PPARg. Mol. Endocrinol. In press.
26. Kersten, S., J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, and W. Wahli. 1999. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103: 1489-1498.
27. Tontonoz, P., E.Hu, R.A. Graves, A. I.Budavari, and B.M. Spiegelman. 1994. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8: 1224-1234.
28. Wang, J., and R. A. Hegele. 2007. Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650). Lipids Health Dis. 6: 23.
29. Gin, P., A. P. Beigneux, B. Davies, M. F. Young, R. O. Ryan, A. Bensadoun, L. G. Fong, and S. G. Young. 2007. Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution. Biochim. Biophys. Acta. 1771: 1464-1468.